Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer

Association Between Prescription Co-Payment Amount and Compliance With Adjuvant Hormonal Therapy in Women With Early-Stage Breast Cancer

(2011) Alfred I. Neugut et al.   JOURNAL OF CLINICAL ONCOLOGY

Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer

(2010) Rebecca L. Sedjo et al.   BREAST CANCER RESEARCH AND TREATMENT

Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients

(2010) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

Patient adherence and persistence with oral anticancer treatment

(2009) K. Ruddy et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Adjuvant Hormonal Therapy Use Among Insured, Low-Income Women With Breast Cancer

(2009) Gretchen Kimmick et al.   JOURNAL OF CLINICAL ONCOLOGY

Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

(2009) Mitch Dowsett et al.   JOURNAL OF CLINICAL ONCOLOGY

The Economic Consequences of Breast Cancer Adjuvant Hormonal Treatments

(2009) Liliana E. Pezzin et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer

(2008) Ann H. Partridge et al.   JOURNAL OF CLINICAL ONCOLOGY

Predictors of Tamoxifen Discontinuation Among Older Women With Estrogen Receptor–Positive Breast Cancer

(2007) Cynthia Owusu et al.   JOURNAL OF CLINICAL ONCOLOGY